Lv7
4840 积分 2024-07-26 加入
Degrader–Antibody Conjugates: Emerging New Modality
7天前
已完结
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy
7天前
已完结
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties
7天前
已完结
Design, Synthesis, In Vitro and In Vivo Evaluation of Cereblon Binding Bruton’s Tyrosine Kinase (BTK) Degrader CD79b targeted Antibody Drug Conjugates
18天前
已完结
In vitro and in vivo ADME of heterobifunctional degraders: a tailored approach to optimize DMPK properties of PROTACs©
1个月前
已完结
Delivering on the promise of protein degraders
1个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
1个月前
已完结
Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective
1个月前
已完结
Delivering on the promise of protein degraders
1个月前
已完结
Property-based optimisation of PROTACs
1个月前
已完结
皖公网安备34019202002308
